250 related articles for article (PubMed ID: 31870439)
21. Microglial lysosome dysfunction contributes to white matter pathology and TDP-43 proteinopathy in GRN-associated FTD.
Wu Y; Shao W; Todd TW; Tong J; Yue M; Koga S; Castanedes-Casey M; Librero AL; Lee CW; Mackenzie IR; Dickson DW; Zhang YJ; Petrucelli L; Prudencio M
Cell Rep; 2021 Aug; 36(8):109581. PubMed ID: 34433069
[TBL] [Abstract][Full Text] [Related]
22. Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic.
Logan T; Simon MJ; Rana A; Cherf GM; Srivastava A; Davis SS; Low RLY; Chiu CL; Fang M; Huang F; Bhalla A; Llapashtica C; Prorok R; Pizzo ME; Calvert MEK; Sun EW; Hsiao-Nakamoto J; Rajendra Y; Lexa KW; Srivastava DB; van Lengerich B; Wang J; Robles-Colmenares Y; Kim DJ; Duque J; Lenser M; Earr TK; Nguyen H; Chau R; Tsogtbaatar B; Ravi R; Skuja LL; Solanoy H; Rosen HJ; Boeve BF; Boxer AL; Heuer HW; Dennis MS; Kariolis MS; Monroe KM; Przybyla L; Sanchez PE; Meisner R; Diaz D; Henne KR; Watts RJ; Henry AG; Gunasekaran K; Astarita G; Suh JH; Lewcock JW; DeVos SL; Di Paolo G
Cell; 2021 Sep; 184(18):4651-4668.e25. PubMed ID: 34450028
[TBL] [Abstract][Full Text] [Related]
23. Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations.
Marian OC; Teo JD; Lee JY; Song H; Kwok JB; Landin-Romero R; Halliday G; Don AS
Acta Neuropathol Commun; 2023 Mar; 11(1):52. PubMed ID: 36967384
[TBL] [Abstract][Full Text] [Related]
24. AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity.
Amado DA; Rieders JM; Diatta F; Hernandez-Con P; Singer A; Mak JT; Zhang J; Lancaster E; Davidson BL; Chen-Plotkin AS
Mol Ther; 2019 Feb; 27(2):465-478. PubMed ID: 30559071
[TBL] [Abstract][Full Text] [Related]
25. Peripheral GRN mRNA and Serum Progranulin Levels as a Potential Indicator for Both the Presence of Splice Site Mutations and Individuals at Risk for Frontotemporal Dementia.
Guven G; Bilgic B; Tufekcioglu Z; Erginel Unaltuna N; Hanagasi H; Gurvit H; Singleton A; Hardy J; Emre M; Gulec C; Bras J; Guerreiro R; Lohmann E
J Alzheimers Dis; 2019; 67(1):159-167. PubMed ID: 30475763
[TBL] [Abstract][Full Text] [Related]
26. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M
Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429
[TBL] [Abstract][Full Text] [Related]
27. Progranulin haploinsufficiency causes biphasic social dominance abnormalities in the tube test.
Arrant AE; Filiano AJ; Warmus BA; Hall AM; Roberson ED
Genes Brain Behav; 2016 Jul; 15(6):588-603. PubMed ID: 27213486
[TBL] [Abstract][Full Text] [Related]
28. Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results.
Sevigny J; Uspenskaya O; Heckman LD; Wong LC; Hatch DA; Tewari A; Vandenberghe R; Irwin DJ; Saracino D; Le Ber I; Ahmed R; Rohrer JD; Boxer AL; Boland S; Sheehan P; Brandes A; Burstein SR; Shykind BM; Kamalakaran S; Daniels CW; David Litwack E; Mahoney E; Velaga J; McNamara I; Sondergaard P; Sajjad SA; Kobayashi YM; Abeliovich A; Hefti F
Nat Med; 2024 May; 30(5):1406-1415. PubMed ID: 38745011
[TBL] [Abstract][Full Text] [Related]
29. Progranulin as a therapeutic target for dementia.
Galimberti D; Fenoglio C; Scarpini E
Expert Opin Ther Targets; 2018 Jul; 22(7):579-585. PubMed ID: 29889573
[TBL] [Abstract][Full Text] [Related]
30. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice.
Götzl JK; Colombo AV; Fellerer K; Reifschneider A; Werner G; Tahirovic S; Haass C; Capell A
Mol Neurodegener; 2018 Sep; 13(1):48. PubMed ID: 30180904
[TBL] [Abstract][Full Text] [Related]
31. Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients.
Valdez C; Wong YC; Schwake M; Bu G; Wszolek ZK; Krainc D
Hum Mol Genet; 2017 Dec; 26(24):4861-4872. PubMed ID: 29036611
[TBL] [Abstract][Full Text] [Related]
32. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
[TBL] [Abstract][Full Text] [Related]
33. Core features of frontotemporal dementia recapitulated in progranulin knockout mice.
Ghoshal N; Dearborn JT; Wozniak DF; Cairns NJ
Neurobiol Dis; 2012 Jan; 45(1):395-408. PubMed ID: 21933710
[TBL] [Abstract][Full Text] [Related]
34. Progranulin as a therapeutic target in neurodegenerative diseases.
Rhinn H; Tatton N; McCaughey S; Kurnellas M; Rosenthal A
Trends Pharmacol Sci; 2022 Aug; 43(8):641-652. PubMed ID: 35039149
[TBL] [Abstract][Full Text] [Related]
35. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
[TBL] [Abstract][Full Text] [Related]
36. Neurovascular dysfunction in GRN-associated frontotemporal dementia identified by single-nucleus RNA sequencing of human cerebral cortex.
Gerrits E; Giannini LAA; Brouwer N; Melhem S; Seilhean D; Le Ber I; ; Kamermans A; Kooij G; de Vries HE; Boddeke EWGM; Seelaar H; van Swieten JC; Eggen BJL
Nat Neurosci; 2022 Aug; 25(8):1034-1048. PubMed ID: 35879464
[TBL] [Abstract][Full Text] [Related]
37. Decreased Prefrontal Activation during Matrix Reasoning in Predementia Progranulin Mutation Carriers.
Alexander C; Zeithamova D; Hsiung GR; Mackenzie IR; Jacova C
J Alzheimers Dis; 2018; 62(2):583-589. PubMed ID: 29480174
[TBL] [Abstract][Full Text] [Related]
38. Human progranulin-expressing mice as a novel tool for the development of progranulin-modulating therapeutics.
Petkau TL; Life B; Lu G; Yang J; Fornes O; Wasserman W; Simpson EM; Leavitt BR
Neurobiol Dis; 2021 Jun; 153():105314. PubMed ID: 33636385
[TBL] [Abstract][Full Text] [Related]
39. Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons.
Hasan S; Fernandopulle MS; Humble SW; Frankenfield AM; Li H; Prestil R; Johnson KR; Ryan BJ; Wade-Martins R; Ward ME; Hao L
Mol Neurodegener; 2023 Nov; 18(1):87. PubMed ID: 37974165
[TBL] [Abstract][Full Text] [Related]
40. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency.
Frew J; Baradaran-Heravi A; Balgi AD; Wu X; Yan TD; Arns S; Shidmoossavee FS; Tan J; Jaquith JB; Jansen-West KR; Lynn FC; Gao FB; Petrucelli L; Feldman HH; Mackenzie IR; Roberge M; Nygaard HB
Mol Neurodegener; 2020 Mar; 15(1):21. PubMed ID: 32178712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
